A revolutionary handheld and battery-powered DNA diagnostic device invented at the University of Otago is poised to become a commonly used field tool for rapidly detecting suspected viruses or bacteria in samples while also determining the level of infection.
The breakthrough device, dubbed Freedom4, will be unveiled today at the Queenstown Molecular Biology main meeting. It takes advantage of a technology called quantitative PCR to identify target DNA sequences in real-time, without the need for further processing.
As an example, using Freedom4, the presence and extent of norovirus infection in a sample could be confirmed within less than an hour, while the person using the unit was still at the outbreak site.
Dr Jo-Ann Stanton, who led the programme to develop the device, says that as well as enabling ‘anytime, anywhere’ clinical diagnosis of viral infectious diseases in humans and animals, it also has many other potential uses, such as border security, forensics or environmental monitoring.
Developed by Dr Stanton’s multidisciplinary team at Otago’s Department of Anatomy, the sturdy unit weighs the same as a typical laptop and fits on the palm of your hand. Freedom4 boasts a six-hour battery life and can be tethered to a laptop, or connect wirelessly to smart phones or tablets running custom software that analyses and interprets the test results.
“This mobility could provide a great boon for farmers. For instance, vets could drive around a farm analysing samples from various locations, make their diagnoses and treat infected animals-all in one trip,” she says.
The Latest on: DNA diagnostics
[google_news title=”” keyword=”DNA diagnostics” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: DNA diagnostics
- APCCC 2024: PSMA Radioligand Therapy – State of the Arton April 27, 2024 at 6:35 am
(UroToday.com) The 2024 Advanced Prostate Cancer Consensus Conference (APCCC) held in Lugano, Switzerland between April 25 th and 27 th was host to PSMA for Diagnostic and Treatment session. Dr. Ken ...
- Scientists discover potential biomarkers of environmental exposures in Parkinson's diseaseon April 26, 2024 at 7:00 am
A team of Northwestern Medicine investigators has discovered novel DNA methylation patterns in the blood of patients with Parkinson's disease, according to findings published in Annals of Neurology.
- Buy Rating Affirmed on Promising CHK1 Inhibitor and Diagnostic Synergyon April 25, 2024 at 11:18 pm
Leerink Partners analyst Andrew Berens has maintained their bullish stance on BOLD stock, giving a Buy rating on April 22. Andrew Berens has ...
- Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcaston April 25, 2024 at 6:30 am
Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its first ...
- Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Programon April 25, 2024 at 5:24 am
Under the terms of the contract, Applied DNA will supply Linea™ DNA IVT templates to HDT Bio for use in conjunction with its LION™ formulated repRNA (self-replicating RNA) vaccination platform. The ...
- World DNA Day 2024: A spotlight on the big ways DNA is changing your worldon April 24, 2024 at 12:31 pm
DNA holds vast potential in healthcare, agriculture, forensics, and environmental sustainability. With genetic testing, modified crops, and DNA databa ...
- Study unveils novel bladder cancer diagnostic model based on key mitochondrial geneson April 24, 2024 at 7:13 am
The researchers analyzed 165 bladder cancer (BC) samples and 67 controls to study the differential expression of mitochondrial-related genes (MRGs). They identified 752 differentially expressed MRGs, ...
- Evolution of Diagnostic Industry: New trends and models transforming the healthcare industryon April 24, 2024 at 5:54 am
The diagnostic industry, a cornerstone of modern healthcare, has undergone a significant transformation over the past few decades.
- Beyond biology: Creating dynamic synthetic cells with programmable DNAon April 22, 2024 at 4:59 pm
This accomplishment, a first in the field, has implications for efforts in regenerative medicine, drug delivery systems, and diagnostic tools ... To do this, they used a new programmable peptide-DNA ...
- Applied DNA Announces 1-For-20 Reverse Stock Spliton April 22, 2024 at 12:25 pm
Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the Company), a leader in PCR-based DNA technologies, today announced that it will effect a 1-for-20 stock split of its common stock, to be ...
via Bing News